Document is current
Any future updates will be listed below
-
Authors
Jansen, Theodorus J.P. https://orcid.org/0000-0002-6466-7838
Tokgöz, Sevilay https://orcid.org/0009-0009-7597-8170
Buitinga, Mijke https://orcid.org/0000-0002-4202-2473
van Lith, Sanne A.M. https://orcid.org/0000-0001-8584-2546
Joosten, Lieke https://orcid.org/0000-0003-4427-8664
Frielink, Cathelijne
Smeets, Esther M. M. https://orcid.org/0000-0002-8350-2131
Stommel, Martijn W.J. https://orcid.org/0000-0002-4257-5254
van der Kolk, Marion B. https://orcid.org/0000-0003-0294-0496
de Galan, Bastiaan E. https://orcid.org/0000-0002-1255-7741
Brom, Maarten https://orcid.org/0000-0001-5755-1477
Boss, Marti https://orcid.org/0000-0002-5837-1803
Gotthardt, Martin https://orcid.org/0000-0002-6537-7744
-
Funding
Funding for this research was provided by:
JDRF (2-SRA-2014-266-M-B)
Diabetes Fonds (2015-81-1845)
FP7 Ideas: European Research Council (602812)
Innovative Medicines Initiative (115797, 948268)
ZonMW (95105008)
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 3 October 2024
First Online: 15 October 2024
Declarations
:
: Both clinical studies were approved by the local Ethics Committee (Commissie Mensgebonden Onderzoek regio Arnhem-Nijmegen, reference number NL47132.091.14 and NL63933.091.17). Both studies were performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All study participants gave written informed consent.
: Written informed consent was obtained from the patients for publication of this study and accompanying images.
: All other authors declare they have no conflicts of interest that are relevant to this study.
